Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China

Vascular

Volumn 22, Issue 3, 2014, Pages 181-187

  Su, Qingjie ^a   Yuan, Kunxiong ^a   Long, Faqing ^a   Wan, Zhongqin ^a   Li, Chaoyun ^b   Cai, Yi ^a   Zeng, Chaosheng ^a   Wu, Yingman ^a   Wu, Hairong ^a   Liu, Shu ^a   Li, Pengxiang ^a   Zhou, Jingxia ^a   Chen, Cong ^a   Wang, Desheng ^a   Yan, Limin ^a   Zhang, Yuhui ^a   Dai, Mingming ^a  

^a Hainan Provincial Nongken Hospital   (China)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

China; compliance; Hainan province; Ischemic stroke; secondary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ANTILIPEMIC AGENT;

AGED; ARTICLE; BRAIN ISCHEMIA; COMPLIANCE (PHYSICAL); DIABETES MELLITUS; FEMALE; HEALTH EDUCATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; CHINA; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; HOSPITAL READMISSION; HYPERLIPIDEMIAS; MULTICENTER STUDY; NEEDS ASSESSMENT; PRACTICE GUIDELINE; PROCEDURES; STATISTICS AND NUMERICAL DATA; STROKE;

AGED; ANTIHYPERTENSIVE AGENTS; BRAIN ISCHEMIA; CHINA; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MALE; NEEDS ASSESSMENT; PATIENT READMISSION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; STROKE;

EID: 84901926695     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1177/1708538113484022     Document Type: Article

References (23)

1. Chen MG,Bona W,Ye XC, et al.Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischemic stroke.J Clin Neurosci. 2011;18 (11): 1454-1457.
2. Demaerschalk BM,Hwang HM,Leung G.US cost burden of ischemic stroke: a systematic literature review.Am J Manag Care. 2010;16 (7): 525-533.
3. Wang YJ,Zhang SM,Zhang LQ, et al.Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010.CNS Neurosci Ther. 2012;18 (2): 93-101.
4. Wei JW,Wang JG,Huang YN, et al.Secondary prevention of ischemic stroke in urban China.Stroke. 2010;41 (5): 967-974.
5. D'Agostino RB,Wolf PA,Belanger AJ, et al.Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.Stroke. 1994;25 (1): 40-43.
6. Wang TJ,Massaro JM,Levy D, et al.A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.JAMA. 2003;290 (8): 1049-1056.
7. Asberg S,Henriksson KM,Farahmand B, et al.Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register.Stroke. 2010;41 (7): 1338-1342.
8. Donnan GA,Fisher M,Macleod M, et al.Stroke.Lancet. 2008;371 (9624): 1612-1623.
9. Kammersgaard LP,Olsen TS.Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study.Cerebrovasc Dis. 2006;21 (3): 187-193.
10. Chinese secondary prevention guidelines for ischemic stroke and transient ischemic attack (2010).Chin J Neurol. 2010;43 (2): 154-160.
11. National Board of Health and Welfare. National Guidelines on Stroke Care, http://www.socialstyrelsen.se/nationellariktlinjer (2007, accessed 4 June 2013).
12. Gotto AMJ.Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease.Arch Intern Med. 1997;157 (12): 1283-1284.
13. Lutsep HL.Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.Am J Med. 2009;122 (4 Suppl. 2): S21-S31.
14. Zhou BF.Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults.Biomed Environ Sci. 2002;15 (1): 83-96.
15. Paciaroni M,Bogousslavsky J.Primary and secondary prevention of ischemic stroke.Eur Neurol. 2010;63 (5): 267-278.
16. Hackam DG,Spence JD.Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study.Stroke. 2007;38 (6): 1881-1885.
17. Holloway RG,Benesch C,Rush SR.Stroke prevention: narrowing the evidence-practice gap.Neurology. 2000;54 (10): 1899-1906.
18. WANG L,Zhang Z,He XF.Status of secondary prevention of 541 recurrent ischemic stroke or TIA patients.Chin J Nervous Mental Dis. 2010;10:594-597.
19. Abbott AL.Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis.Stroke. 2009;40 (10): e573-e583.
20. Naylor AR,Mehta Z,Rothwell PM.A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass.Eur J Vasc Endovasc Surg. 2009;37 (4): 379-387.
21. Spence JD.Asymptomatic carotid stenosis: mainly a medical condition.Vascular. 2010;18 (3): 123-126.
22. Adams RJ,Albers G,Alberts MJ, et al.Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.Stroke. 2008;39 (5): 1647-1652.
23. Sacco RL,Adams R,Albers G, et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.Circulation. 2006;113 (10): 409-449.